Cargando…
Human Milk Oligosaccharides: Health Benefits, Potential Applications in Infant Formulas, and Pharmacology
The first months of life are a special time for the health development and protection of infants. Breastfeeding is the natural and best way of feeding an infant, and positively influences their development and health. Breast milk provides the ideal balance of nutrients for the infant and contains co...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7019891/ https://www.ncbi.nlm.nih.gov/pubmed/31968617 http://dx.doi.org/10.3390/nu12010266 |
_version_ | 1783497623909433344 |
---|---|
author | Wiciński, Michał Sawicka, Ewelina Gębalski, Jakub Kubiak, Karol Malinowski, Bartosz |
author_facet | Wiciński, Michał Sawicka, Ewelina Gębalski, Jakub Kubiak, Karol Malinowski, Bartosz |
author_sort | Wiciński, Michał |
collection | PubMed |
description | The first months of life are a special time for the health development and protection of infants. Breastfeeding is the natural and best way of feeding an infant, and positively influences their development and health. Breast milk provides the ideal balance of nutrients for the infant and contains countless bioactive ingredients such as immunoglobulins, hormones, oligosaccharides and others. Human milk oligosaccharides (HMOs) are a very important and interesting constituent of human milk, and are the third most abundant solid component after lactose and lipids. They are a structurally and biologically diverse group of complex indigestible sugars. This article will discuss the mechanisms of action of HMOs in infants, such as their anti-adhesive properties, properties modulating the immune system, and impact on bacterial flora development. Many health benefits result from consuming HMOs. They also may decrease the risk of infection by their interactions with viruses, bacteria or protozoa. The commercial use of HMOs in infant formula, future directions, and research on the use of HMOs as a therapy will be discussed. |
format | Online Article Text |
id | pubmed-7019891 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-70198912020-03-09 Human Milk Oligosaccharides: Health Benefits, Potential Applications in Infant Formulas, and Pharmacology Wiciński, Michał Sawicka, Ewelina Gębalski, Jakub Kubiak, Karol Malinowski, Bartosz Nutrients Article The first months of life are a special time for the health development and protection of infants. Breastfeeding is the natural and best way of feeding an infant, and positively influences their development and health. Breast milk provides the ideal balance of nutrients for the infant and contains countless bioactive ingredients such as immunoglobulins, hormones, oligosaccharides and others. Human milk oligosaccharides (HMOs) are a very important and interesting constituent of human milk, and are the third most abundant solid component after lactose and lipids. They are a structurally and biologically diverse group of complex indigestible sugars. This article will discuss the mechanisms of action of HMOs in infants, such as their anti-adhesive properties, properties modulating the immune system, and impact on bacterial flora development. Many health benefits result from consuming HMOs. They also may decrease the risk of infection by their interactions with viruses, bacteria or protozoa. The commercial use of HMOs in infant formula, future directions, and research on the use of HMOs as a therapy will be discussed. MDPI 2020-01-20 /pmc/articles/PMC7019891/ /pubmed/31968617 http://dx.doi.org/10.3390/nu12010266 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Wiciński, Michał Sawicka, Ewelina Gębalski, Jakub Kubiak, Karol Malinowski, Bartosz Human Milk Oligosaccharides: Health Benefits, Potential Applications in Infant Formulas, and Pharmacology |
title | Human Milk Oligosaccharides: Health Benefits, Potential Applications in Infant Formulas, and Pharmacology |
title_full | Human Milk Oligosaccharides: Health Benefits, Potential Applications in Infant Formulas, and Pharmacology |
title_fullStr | Human Milk Oligosaccharides: Health Benefits, Potential Applications in Infant Formulas, and Pharmacology |
title_full_unstemmed | Human Milk Oligosaccharides: Health Benefits, Potential Applications in Infant Formulas, and Pharmacology |
title_short | Human Milk Oligosaccharides: Health Benefits, Potential Applications in Infant Formulas, and Pharmacology |
title_sort | human milk oligosaccharides: health benefits, potential applications in infant formulas, and pharmacology |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7019891/ https://www.ncbi.nlm.nih.gov/pubmed/31968617 http://dx.doi.org/10.3390/nu12010266 |
work_keys_str_mv | AT wicinskimichał humanmilkoligosaccharideshealthbenefitspotentialapplicationsininfantformulasandpharmacology AT sawickaewelina humanmilkoligosaccharideshealthbenefitspotentialapplicationsininfantformulasandpharmacology AT gebalskijakub humanmilkoligosaccharideshealthbenefitspotentialapplicationsininfantformulasandpharmacology AT kubiakkarol humanmilkoligosaccharideshealthbenefitspotentialapplicationsininfantformulasandpharmacology AT malinowskibartosz humanmilkoligosaccharideshealthbenefitspotentialapplicationsininfantformulasandpharmacology |